Want to see IN:BLUEJET full AI Analyst Report?
BLUEJET Stock Chart & Stats
₹653.45
-₹16.80(-2.80%)
At close: 4:00 PM EST
₹653.45
-₹16.80(-2.80%)
Day’s Range― - ―
52-Week Range₹325.20 - ₹1,021.75
Previous CloseN/A
Volume75.53K
Average Volume (3M)19.19K
Market Cap
₹111.63B
Enterprise Value₹86.59B
Total Cash (Recent Filing)₹3.76B
Total Debt (Recent Filing)₹421.84M
Price to Earnings (P/E)41.2
Beta1.42
Next Earnings
Aug 11, 2026EPS Estimate
4.2Next Dividend Ex-DateN/A
Dividend Yield0.2%
Share Statistics
EPS (TTM)14.30
Shares Outstanding189,275,700
10 Day Avg. Volume15,409
30 Day Avg. Volume19,187
Financial Highlights & Ratios
PEG Ratio-1.22
Price to Book (P/B)4.17
Price to Sales (P/S)5.99
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹370.00Price Target Upside-43.38% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
EPS Forecast (FY)17.25
Revenue Forecast (FY)₹11.66B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage (debt-to-equity ~0.031 in FY2026) and a steadily expanding equity base provide durable financial flexibility. This reduces solvency risk, allows funding of compliance/capacity needs without reliance on external debt, and supports resilience through sector cycles.
Sustained High MarginsConsistently strong gross and net margins (net margin ~22%–30% FY2021–FY2026) reflect pricing power and cost control in niche APIs. Durable margin levels support high returns on capital, enable reinvestment in technical capabilities, and act as a buffer during volume or pricing cycles.
Niche, Complex API FocusSpecialization in complex chemistries for regulated and semi-regulated markets creates meaningful technical barriers, customer stickiness, and higher switching costs. This business model supports long-term stable demand, premium pricing, and defensible margins vs commoditized API players.
Bears Say
Sharp Recent Revenue DeclineA material FY2026 revenue drop (~-20%) after prior growth suggests demand loss, adverse mix, or customer concentration risks. Sustained revenue weakness would reduce operating leverage, constrain reinvestment, and could erode the company’s ability to fund growth or defend margins over the medium term.
Volatile Cash ConversionInconsistent operating cash flow and FCF profile point to working-capital swings or timing issues. Unreliable cash generation limits capacity for sustained capex, reduces flexibility to weather cycles, and increases dependence on external funding for strategic investments when needed.
Margin Pressure / Choppy Operating MomentumReported margin compression and choppy growth indicate potential structural mix shifts or pricing pressures in key products. If persistent, this undermines the durability of historically strong returns and makes profitability more sensitive to volume declines or competitive intensity.
Blue Jet Healthcare Limited News
BLUEJET FAQ
What was Blue Jet Healthcare Limited’s price range in the past 12 months?
Blue Jet Healthcare Limited lowest stock price was ₹325.20 and its highest was ₹1021.75 in the past 12 months.
What is Blue Jet Healthcare Limited’s market cap?
Blue Jet Healthcare Limited’s market cap is ₹111.63B.
When is Blue Jet Healthcare Limited’s upcoming earnings report date?
Blue Jet Healthcare Limited’s upcoming earnings report date is Aug 11, 2026 which is in 20 days.
How were Blue Jet Healthcare Limited’s earnings last quarter?
Blue Jet Healthcare Limited released its earnings results on May 25, 2026. The company reported ₹3.7 earnings per share for the quarter, beating the consensus estimate of ₹2.55 by ₹1.15.
Is Blue Jet Healthcare Limited overvalued?
According to Wall Street analysts Blue Jet Healthcare Limited’s price is currently Overvalued.
Does Blue Jet Healthcare Limited pay dividends?
Blue Jet Healthcare Limited pays a Notavailable dividend of ₹1.2 which represents an annual dividend yield of 0.2%. See more information on Blue Jet Healthcare Limited dividends here
What is Blue Jet Healthcare Limited’s EPS estimate?
Blue Jet Healthcare Limited’s EPS estimate is 4.2.
How many shares outstanding does Blue Jet Healthcare Limited have?
Blue Jet Healthcare Limited has 189,275,700 shares outstanding.
What happened to Blue Jet Healthcare Limited’s price movement after its last earnings report?
Blue Jet Healthcare Limited reported an EPS of ₹3.7 in its last earnings report, beating expectations of ₹2.55. Following the earnings report the stock price went up 9.522%.
Which hedge fund is a major shareholder of Blue Jet Healthcare Limited?
Currently, no hedge funds are holding shares in IN:BLUEJET
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blue Jet Healthcare Limited
Blue Jet Healthcare Ltd. is a company that focuses on the manufacturing and supply of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), which are critical components for the pharmaceutical and healthcare sectors. Its product offerings include integrated intermediates used in contrast media, saccharin and its associated salts, and a range of specialized pharmaceutical intermediates and APIs. The company also delivers comprehensive contract development and manufacturing (CDMO/CMO) and development services. Founded in 1968, Blue Jet Healthcare is headquartered in Thane, India, and maintains a broad international operational footprint across countries such as India, Norway, the United States, Sweden, Italy, and Spain.
BLUEJET Stock 12 Month Forecast
Average Price Target
₹370.00
▼(-43.38% Downside)
Technical Analysis
Biocon Limited
―
Concord Biotech Ltd.
―
Dishman Carbogen Amcis Ltd.
―
Syngene International Ltd.
―
OneSource Specialty Pharma Limited
―